1. Home
  2. UP vs PRQR Comparison

UP vs PRQR Comparison

Compare UP & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wheels Up Experience Inc.

UP

Wheels Up Experience Inc.

HOLD

Current Price

$8.71

Market Cap

182.3M

ML Signal

HOLD

Logo ProQR Therapeutics N.V.

PRQR

ProQR Therapeutics N.V.

HOLD

Current Price

$1.47

Market Cap

166.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UP
PRQR
Founded
2013
2012
Country
United States
Netherlands
Employees
1250
N/A
Industry
Aerospace
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
182.3M
166.5M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
UP
PRQR
Price
$8.71
$1.47
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$7.25
AVG Volume (30 Days)
223.7K
552.2K
Earning Date
05-12-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$13.92
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.36
$1.33
52 Week High
$9.97
$3.10

Technical Indicators

Market Signals
Indicator
UP
PRQR
Relative Strength Index (RSI) 63.65 42.29
Support Level $0.79 $1.37
Resistance Level N/A $1.58
Average True Range (ATR) 1.05 0.11
MACD 0.05 -0.00
Stochastic Oscillator 72.76 27.63

Price Performance

Historical Comparison
UP
PRQR

About UP Wheels Up Experience Inc.

Wheels Up Experience Inc is a provider of on-demand private aviation. The company offers a private aviation solution with a large and diverse aircraft fleet, delivered through a mix of charter solutions and its membership program that utilizes its controlled aircraft fleet and a network of safety-vetted charter operators. Through its partnership firm, it provides members and customers with an offering across private and premium commercial travel. It generates the majority of its revenue from member and customer flights through its membership program and charter solutions, as well as from membership fees and other activities and services, including group charter flights, cargo flights, and special missions. Geographically, the company generates maximum revenue from the United States.

About PRQR ProQR Therapeutics N.V.

ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics. Geographically, the company operates in United States.

Share on Social Networks: